Universal Leukocyte Reduction To Double Annual Blood Filtration Market
This article was originally published in The Gray Sheet
Executive Summary
Universal leukocyte reduction of all blood units used for transfusions in the U.S. would roughly double the market for the blood filters to about $420 mil., annually.
You may also be interested in...
Potential Blood Supply Reduction Counts Against HHS Filtration Policy - CAP
HHS should evaluate and conduct studies to determine the effect of universal leukoreduction on the nation's blood supply, according to the College of American Pathologists and seven other health specialty groups.
Potential Blood Supply Reduction Counts Against HHS Filtration Policy - CAP
HHS should evaluate and conduct studies to determine the effect of universal leukoreduction on the nation's blood supply, according to the College of American Pathologists and seven other health specialty groups.
Pall Will Seek To Aid FDA In U.S. Leukocyte Filtration Initiatives
Pall Corporation will aid FDA through broad-scale programs in implementing routine leukocyte filtration of the U.S. blood supply, the company says.